SUBMISSION OF ABSTRACTS
Submission deadline: Friday 8 March 2024
Abstracts must be submitted using the online form.
Criteria for abstract for oral presentation
Must be original research.
Must include study results of a trial or trial substudy or pipeline towards a clinical trial.
References are not required.
Abstracts reporting on studies at a very early stage or study protocols will not be accepted.
Drugs should be referred to by their generic name. The use of trade names should be avoided unless necessary.
The main source of funding of a study should be indicated at the end of the abstract.
Abstract structure and assessment criteria for oral presentation
Abstracts must be structured and will be assessed, based on the following criteria:
Aims-background-context: relevance of hypothesis, clearly stated aims.
Quality of methods: sampling, data collection, analytical strategy; stringency of theoretical position, reference to relevant knowledge base etc.
Relevance to palliative care/cancer symptoms and pipeline to trial or clinical trial: All abstracts should demonstrate relevance to some aspect of palliative care practice or cancer symptom management, policy or research work, or contribute to a relevant theoretical or methodological debate in these patient populations.
Originality of research: the presentation of new data or new concepts. Stringency of arguments when repeating previous work.
Clear presentation of results: data interpretation, statistical power, application to palliative care or cancer symptoms management, etc.
Conclusions: supported by the data presented, quality of the interpretation of own work.
Submission process
You may wish to draft your submission in a Word document first so that you can copy and paste into the online form.
Click the button below to access and complete the online form.
We will confirm via email that your submission has been received.
Any changes after submission (for example withdrawal of abstract, change of presenting author etc.) should be emailed to cst@uts.edu.au, including complete contact information of any new presenters.
After the review process, the abstracts will be allocated to the Forum program, and all corresponding authors will be notified by email of the decision of the review panel by Friday 15 March 2024.